Lucintel's latest market report analyzed that 3D bioprinting provides attractive opportunities in the pharmaceutical & biotechnology and research organizations & academic institutes. The 3D bioprinting market is expected to reach $5.0 billion by 2028 with a CAGR of 18.4%. In this market, 3D bioprinters is the largest segment by product, whereas research organizations & academic...